Nick Burgin News Today

Treatment involves early Alzheimer’s disease and will be potentially used across Great Britain - News - PharmaTimes

UK medicines revenue clawback rockets to 26.5% putting Life Sciences Vision at risk, says ABPINext year manufacturers of branded medicines will be required to return almost £3.3bn in sales revenue to the government (26.5% of sales), up from around £0.6bn in 2021 and £1.8bn in 2022 [1].Company react...